Practice and exploration of physician-pharmacist joint outpatient service mode of chronic obstructive pulmonary disease (COPD) and asthma
10.12206/j.issn.2097-2024.202209034
- VernacularTitle:咳喘医药联合门诊服务模式的实践与探索
- Author:
Dan CHEN
1
,
2
;
Guodong LIU
1
,
2
;
Yu LIU
1
,
2
;
Shaohua TONG
1
,
2
;
Shengjun LIU
1
,
2
Author Information
1. a. Department of Pharmacy
2. b. Department of Oncology, 95829 Military Hospital, Wuhan 430001 China.
- Keywords:
asthma;
chronic obstructive pulmonary disease;
joint clinic;
inhaler device;
pharmaceutical care
- From:
Journal of Pharmaceutical Practice
2023;41(11):689-693
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the physician-pharmacist joint outpatient service mode of chronic obstructive pulmonary disease ( COPD) and asthma. Methods Cases of COPD or asthma patients who visited the joint outpatient department from June 2021 to December 2021 were collected in our hospital, the inhaler usage score，compliance ( MMAS-8) score，clinical control efficacy，incidence of adverse reactions and patient satisfaction were evaluated before and after pharmaceutical care intervention and statistically analyzed．Results The inhaler usage score，MMAS-8 score，and the Asthma Control Test（ACT）/COPD Assessment Test（CAT） score had been changed significantly after the intervention (P<0.05). Patient satisfaction with pharmaceutical care was basically above 94.75%．Conclusion Pharmaceutical care provided by joint outpatient department in our hospital could help COPD and asthma patients to use inhaler device correctly，resulting in improving compliance of inhaler usage, better disease control，and reducing the occurrence of adverse drug reactions, which could be a positive attempt and exploration of standardized pharmaceutical care model for patients with COPD and asthma．
